Schering-Plough gets Japan OK for Zetia |
|
|
|
Published
:
Thu, 19 Apr 2007 00:47
|
KENILWORTH, N.J. (AP) - Drug maker Schering-Plough Inc. on Wednesday said it received Japanese marketing approval for its cholesterol-lowering drug Zetia.Zetia will be co-marketed in Japan with Bayer Yakuhin Ltd., Schering-Plough said.Zetia will not become available in Japan until National Health Insurance Reimbursement price listing.Schering-Plough received approval from the Food and Drug administration for Zetia in 2002, and the medication has been approved in 90 countries worldwide.Shares rose 40 cents to close at $28.55 on the New York Stock Exchange.Copyright 2007 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2792.28 |
22.57 (
0.81 %)
|
| SYMBOL (
2012-01-19 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
11:35am )
|
|
2017.00 |
46.00 (
2.42 %)
|
|
WHITBREAD
(
11:35am )
|
|
1662.99 |
33.99 (
2.09 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
IBM
(
12:34pm ) |
|
181.50 |
0.43 (
0.24 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
|
Print this Story
N.J. firms to develop cholesterol combo 